• Provider Login
  • Payors
  • Manufacturers
  • Blog
  • Careers
Avella Specialty Pharmacy
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact
Menu
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact

Specialty Pharmacy Insights

Return to blog

Avella Launches Pain & Addiction Management Mobile App for Physicians

Posted by Avella Specialty Pharmacy on Fri, Sep 15, 2017
  • Tweet

Avella Specialty Pharmacy recently announced that it has launched a new mobile app aimed at care providers who manage patients suffering from chronic pain or an addiction to pain medication or other substances. This Pain and Addiction Management Mobile App will provide much-needed guidance and support for providers in the wake of the opioid epidemic and tightening regulations around the prescribing of certain pain medications.

 
 
 
 
 
 
 
 
 
 
 
1:01
 
 
 
1:01
 
 
 
  • Speed
    1x
  • Quality
    720p
 
 
 
 
 
 
 
 
Wistia video thumbnail - Pain and Addiction Management App
About WistiaReport a problemCopy link and thumbnail
 

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?

 
Cancel
message
 
 
 
 
 
 
 


More than twenty-five million Americans, or more than one in ten people, experience chronic pain daily according to the National Institutes for Health. This legitimate need for pain relief is exceedingly difficult to manage given the inherent risks involved in prescribing powerful narcotics. In 2015, opioid drug overdoses led to the death of 33,000 people in this country as reported by the CDC, greater than any year on record. Approximately half of these deaths involved a prescription opioid.

In response to this crisis, many new non-narcotic medications are now being introduced to treat chronic pain, along with therapies designed to help patients addicted to prescription opioids. Given all of these options now available, along with an increasingly regulated prescribing landscape, Avella identified a need to help providers identify the most appropriate, safe and effective medications for their patients.

Avella’s new mobile app provides information about a variety of pain and addiction management medications available from different manufacturers, all in one place. Prescribers can search for clinical information by medication name or category for 45+ pain and addiction management medications including:

  • Anti-Depressants
  • Fast Acting/Breakthrough
  • Long Acting
  • Stimulants
  • Transmucosal Immediate Release Fentanyl (TIRF)
  • Addiction medications like Vivitrol, Probuphine and Suboxone

The app also hosts detailed medication information such as indication and usage, dosage and administration, contraindications, warnings, adverse reactions and more. The mobile app is updated frequently to assist in the prescribing of pain and addiction management medications.

Aside from medication information, users can access powerful tools within the app. This includes drug dosage calculators and opioid converters, which can be used to transition patients to a new medication while maintaining safety and efficacy of treatment. The app also features industry news, professional organizations, conferences and continuing medical education, as well as evidence-based prescribing guidelines from the Centers for Disease Control and Prevention and the American Society of Addiction Medicine.

“Prescribing pain medications has always been a difficult task given the safety risks, addiction potential and side effects of certain powerful narcotics,” said Eric Sredzinski, Pharm.D, EVP of Clinical Affairs and Quality Assurance Program Director for Avella. “Today it is more challenging than ever, which is why we’re looking to support our provider partners as they help patients manage chronic pain while preventing the devastating impact of opioid addiction.”

The Pain and Addiction Management Mobile App from Avella is now available on the Apple App store, providers can search for “Pain Management Medication App.” Learn more about Avella's Pain and Addiction Management mobile app today.

Watch the Video & Get Started

Topics Pain Management

CONNECT WITH US

  • social-twitter
  • social-linkedin
  • social-youtube
  • social-facebook
  • social-yelp

Subscribe For Updates

Recent Posts

Posts by Topic

  • Avella (28)
  • Oncology (23)
  • Specialty Pharmacy (18)
  • Hepatitis (14)
  • Adherence (12)
  • HIV/AIDS (6)
  • Medication (6)
  • Cancer (5)
  • Fertility (5)
  • limited distribution drugs (4)
  • Accreditations (3)
  • Patients (3)
  • Public Health (3)
  • Addiction Management (2)
  • Pain Management (2)
  • mobile health (2)
  • 340b Program (1)
  • Complex Disease (1)
  • Dermatology (1)
  • IG Therapy (1)
  • In the News (1)
  • Inc (1)
  • Inc 5000 (1)
  • Industry News (1)
  • Infusion Therapy (1)
  • LLS (1)
  • Managed Care (1)
  • Partners (1)
  • Pharmacist (1)
  • Psoriasis (1)
  • RSV (1)
  • Rheumatoid Arthritis (1)
  • outsourcing facility (1)
  • payers (1)
see all
  • specialty_accreditation_seal-1
  • rsz_mail_service_accreditationseal
  • Addiction Management
  • Cardiovascular Disease
  • Dermatology
  • Fertility
  • Gastroenterology
  • Hepatitis
  • HIV / AIDS
  • Infusion Therapy
  • IG Therapy
  • Multiple Sclerosis
  • Oncology
  • Ophthalmology
  • Rheumatology
  • RSV
  • Transplant
  • Urology
  • Contact Avella
  • Terms of Use
  • Privacy
  • Blog
  • 877-546-5779
© 2025 Avella Specialty Pharmacy
  • Twitter
  • LinkedIn
  • YouTube
  • Facebook
.